ES2223110T3 - Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b. - Google Patents

Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b.

Info

Publication number
ES2223110T3
ES2223110T3 ES98400711T ES98400711T ES2223110T3 ES 2223110 T3 ES2223110 T3 ES 2223110T3 ES 98400711 T ES98400711 T ES 98400711T ES 98400711 T ES98400711 T ES 98400711T ES 2223110 T3 ES2223110 T3 ES 2223110T3
Authority
ES
Spain
Prior art keywords
dihydro
piperidin
benzodioxin
fumarate
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98400711T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Valerie Audinot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Application granted granted Critical
Publication of ES2223110T3 publication Critical patent/ES2223110T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES98400711T 1997-03-27 1998-03-26 Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b. Expired - Lifetime ES2223110T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703760A FR2761358B1 (fr) 1997-03-27 1997-03-27 Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR9703760 1997-03-27

Publications (1)

Publication Number Publication Date
ES2223110T3 true ES2223110T3 (es) 2005-02-16

Family

ID=9505236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98400711T Expired - Lifetime ES2223110T3 (es) 1997-03-27 1998-03-26 Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b.

Country Status (17)

Country Link
US (1) US5965575A (2)
EP (1) EP0867436B1 (2)
JP (1) JPH10279578A (2)
CN (1) CN1090628C (2)
AT (1) ATE268767T1 (2)
AU (1) AU731018B2 (2)
BR (1) BR9803295A (2)
CA (1) CA2232116C (2)
DE (1) DE69824332T2 (2)
DK (1) DK0867436T3 (2)
ES (1) ES2223110T3 (2)
FR (1) FR2761358B1 (2)
NO (1) NO314628B1 (2)
NZ (1) NZ330041A (2)
PL (1) PL194118B1 (2)
PT (1) PT867436E (2)
ZA (1) ZA982607B (2)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
JP2002535365A (ja) * 1999-01-28 2002-10-22 ブリストル−マイヤーズ スクイブ カンパニー 抗うつ性複素環化合物
EP1189900B1 (en) * 1999-06-30 2004-01-14 Bristol-Myers Squibb Company Heterocyclic aminopyrrolidine derivatives as melatonergic agents
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
NZ535574A (en) * 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
WO2002069973A1 (en) * 2001-03-02 2002-09-12 Sepracor, Inc. Piperidine-piperazine ligand for neurotransmitter receptors
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
ES2331519T3 (es) * 2003-06-30 2010-01-07 Nycomed Gmbh Derivados de pirrolo-dihidroisoquinolina como inhibidores de pde10.
RS20050945A (sr) * 2003-06-30 2008-06-05 Altana Pharma Ag., Novi pirolodihidroizohinolini koji se mogu upotrebiti u tretmanu kancera
EP1661894A4 (en) * 2003-07-14 2007-02-28 Ube Industries METHOD FOR PRODUCING 4-AMINOTETRAHYDROPYRANES AND THEIR SALTS WITH ACIDS, INTERMEDIATE PRODUCTS FOR THE METHOD AND METHOD FOR THE PRODUCTION THEREOF
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
AU2006218054A1 (en) * 2005-01-12 2006-08-31 Nycomed Gmbh Novel pyrrolodihydroisoquinolines as PDE10 inhibitors
WO2006075012A2 (en) * 2005-01-12 2006-07-20 Nycomed Gmbh Pyrrolodihydroisoquinolines as antiproliferative agents
US8599822B2 (en) * 2005-03-23 2013-12-03 Cisco Technology, Inc. Slot-based transmission synchronization mechanism in wireless mesh networks
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
MX2008014450A (es) 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.
BRPI0809106A2 (pt) 2007-03-22 2014-08-26 Astrazeneca Ab Derivados de quinolina para o tratamento de doenças inflamatórias
US8106073B2 (en) 2007-11-30 2012-01-31 Astrazeneca Ab Quinoline derivatives 057
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ATE268767T1 (de) 2004-06-15
BR9803295A (pt) 2000-03-21
EP0867436A1 (fr) 1998-09-30
EP0867436B1 (fr) 2004-06-09
FR2761358A1 (fr) 1998-10-02
DE69824332D1 (de) 2004-07-15
FR2761358B1 (fr) 1999-05-07
PL325575A1 (en) 1998-09-28
CA2232116C (fr) 2003-09-16
CN1197072A (zh) 1998-10-28
DE69824332T2 (de) 2005-06-16
PL194118B1 (pl) 2007-04-30
JPH10279578A (ja) 1998-10-20
AU731018B2 (en) 2001-03-22
DK0867436T3 (da) 2004-10-04
HK1014954A1 (en) 1999-10-08
US5965575A (en) 1999-10-12
CA2232116A1 (fr) 1998-09-27
NO981415L (no) 1998-09-28
PT867436E (pt) 2004-09-30
NO314628B1 (no) 2003-04-22
AU5967798A (en) 1998-10-01
CN1090628C (zh) 2002-09-11
NO981415D0 (no) 1998-03-27
ZA982607B (en) 1998-09-30
NZ330041A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
ES2223110T3 (es) Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b.
JP3421323B2 (ja) ピペリジンｃｃｒ−３受容体拮抗薬
ES2296763T3 (es) Pirrolidinas disustituidas en 1,3 como amtagonistas de adrenorreceptor alfa-2.
ES2322068T3 (es) Derivados de n-(1h-indol-5-il)naftaleno-1-sulfonamida y compuestos relacionados como antagonistas del receptor de serotonina 5-ht6 para el tratamiento de trastornos del sistema nervioso central.
ES2428751T3 (es) Derivados de cromona, un procedimiento para su preparación y aplicaciones terapéuticas de los mismos
KR20100133016A (ko) 니코틴성 아세틸콜린 수용체 아형 알파-71의 조절인자로서의 인돌
HUP0101511A2 (hu) 1-[(1-Szubsztituált-4-piperidinil)-metil]-4-piperidin-származékok, eljárás a vegyületek előállítására, a vegyületeket tartalmazó gyógyászati készítmények és intermedierjeik
JPWO2009022731A1 (ja) Ｐ２ｘ４受容体拮抗剤
RU2060254C1 (ru) Замещенные 3-(пиридиниламино)-индолы или -бензо(в)тиофены и способ их получения
CZ20022319A3 (cs) Substituovaná fenylpiperazinová sloučenina a farmaceutický prostředek, který ji obsahuje
ES2219853T3 (es) Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TWI360540B (en) Tetrahydroisoquinolylsulphonamide derivatives, the
BR112013007073B1 (pt) Derivados do cromeno; composição farmacêutica; utilização de um composto da fórmula i e processo de preparação de um composto da fórmula i
ES2257168B1 (es) Ligandos del receptor 5-ht7.
US6153625A (en) Indan-1-ol compounds
JPH05202063A (ja) イミダゾ［２，１−ｂベンゾチアゾール−３−アセタミド誘導体、その製造および医薬への応用
ES2226726T3 (es) Tetrahidroquinazolina-2,4-diona y usos terapeuticos de la misma.
ES2301979T3 (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la reabsorcion de serotonina.
ES2288744T3 (es) Derivados de 4-amino-5-cianopirimidina.
KR20000035942A (ko) 치환 1,2,3,4-테트라히드로-2-디벤조푸란아민 및2-아미노시클로헵타[ｂ]벤조푸란
JP2008509961A (ja) ５−ｈｔ７受容体アンタゴニスト
ES2251514T3 (es) Ligandos del receptor serotonina de aminoalquilpirrolidina y composiciones, sus usos farmaceuticos y metodos para su sintesis.
McQuaid et al. Substituted 5-amino-4, 5, 6, 7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity
BR112020008583A2 (pt) derivados de imidazopiridina e uso dos mesmos como medicamento
ES2202879T3 (es) Derivados halogenados de 2,3-benzodiazepina triciclica y composiciones farmaceuticas que los contienen.